Bonus Presentations

Speaker: Marc Agronin, MD

Join us for a symposia to review the disease pathology of agitation associated with Alzheimer’s Disease and clinical trial data for a medication.

Speaker: Niku Singh, MD

This program focuses on the implications of unresolved symptoms in patients with major depressive disorder treated with antidepressant monotherapy. We will review common barriers to full remission, evaluate the rationale for adjunctive atypical antipsychotic therapy, and discuss clinical trial evidence that can guide psychiatric treatment decisions.

Speaker: Rebecca Roma, MD

Speaker: Leslie Citrome, MD

In this program, we will explore the burden and consequences associated with relapse in schizophrenia and highlight the potential opportunities of long-acting treatment options. We will review the efficacy, safety, and administration of a new long-acting injectable (LAI) and discuss clinician-driven factors and features of LAIs that may contribute to bottlenecks in LAI utilization.

Speaker: Jane Jesse, MD

This presentation will provide information on tardive dyskinesia (TD), including evolving practices for identifying and assessing TD and understanding and evaluating the impact of TD on patients. Additionally, the session explores AUSTEDO XR as an FDA-approved treatment option for adults with TD.

Speaker: Parinda Parikh, MD

Don’t miss this opportunity to explore a unique treatment approach for adults with schizophrenia. This program highlights the clinical profile of this treatment approach, key considerations for patient selection and initiation, and practical insights for real world use.

Speaker: Joseph F. Goldberg, MD

This promotional program will provide an overview of the clinical data and information for use in clinical practice for a treatment option for adult patients living with bipolar l disorder or schizophrenia.